Nonexudative age-related macular degeneration, bilateral, advanced atrophic with subfoveal involvement digital illustration

Nonexudative age-related macular degeneration, bilateral, advanced atrophic with subfoveal involvement Save


ICD-10 code: H35.3134

Disease category: H35.313: Nonexudative age-related macular degeneration, bilateral

Nonexudative Age-Related Macular Degeneration, Bilateral, Advanced Atrophic with Subfoveal Involvement

Nonexudative age-related macular degeneration (AMD) is a common eye condition that affects a significant number of individuals, particularly those aged 50 and above. This article focuses on the advanced atrophic form of nonexudative AMD with subfoveal involvement, providing insights into the condition without discussing treatment options.

Advanced atrophic AMD is characterized by the progressive degeneration of the macula, a small area in the center of the retina responsible for sharp central vision. When the degeneration occurs bilaterally and involves the subfoveal region, it can have a substantial impact on a person's visual function and quality of life.

One of the key features of advanced atrophic AMD is the presence of drusen, yellow deposits that accumulate beneath the macula. These drusen are a hallmark sign of the condition and can be identified during an eye examination. As the disease progresses, the macula thins and loses its function, leading to a decline in central vision.

Individuals with advanced atrophic AMD often experience difficulties with tasks such as reading, recognizing faces, and driving. The ability to see fine details and perceive colors may also be impaired. However, it is important to note that peripheral vision remains unaffected, allowing individuals to maintain some level of functional vision.

While the exact causes of nonexudative AMD are not fully understood, several risk factors have been identified. These include age, genetics, smoking, hypertension, and a high-fat diet. It is essential for individuals at risk or diagnosed with AMD to adopt a healthy lifestyle and undergo regular eye examinations to monitor disease progression.

  1. Avoid smoking and exposure to secondhand smoke.
  2. Consume a balanced diet rich in fruits, vegetables, and omega-3 fatty acids.
  3. Maintain a healthy blood pressure level.
  4. Protect your eyes from ultraviolet (UV) radiation by wearing sunglasses and hats.
  5. Exercise regularly to promote overall health and well-being.

In conclusion, advanced atrophic AMD with subfoveal involvement is a serious eye condition that can severely impact a person's central vision. Understanding the characteristics and risk factors associated with this condition is crucial for early detection and management. Although treatment options were not discussed in this article, it is important to consult with an eye care professional for a comprehensive evaluation and appropriate guidance.

Treatment of Nonexudative age-related macular degeneration, bilateral, advanced atrophic with subfoveal involvement:

Treatment Options for Nonexudative Age-Related Macular Degeneration, Bilateral, Advanced Atrophic with Subfoveal Involvement

Nonexudative age-related macular degeneration (AMD) is a progressive eye condition that affects the central part of the retina, known as the macula. In advanced cases with subfoveal involvement, treatment options become crucial in managing the disease and pre...

To see full information about treatment please Sign up or Log in